SH
Seth Harmon
DELAYED 1 MONTH
Chief Financial Officer
Viridian Therapeutics, Inc.\DE
Filings
3
Companies
1
Latest
Mar 3, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Viridian Therapeutics, Inc.\DE
Seth Harmon
Chief Financial Officer
Option Exercise
—
6,267 sh
Mar 5 12:15 AM
Mar 3, 2026